RHO and neoplasm: The synthetic multiprotein complex SST3‐Avi‐C3 prepared in this fashion exhibits selective cell uptake, specific inhibition of Rho in cancer cells, pH‐induced release into the cytosol of tumor cells and thereby significantly boosting the antitumor potency of a marketed anticancer therapeutic (Figure 1).